Development of malignant tumor in renal transplant recipients and their NK and LAK activity

[1]  R. Herberman,et al.  Generation and characterization of purified adherent lymphokine-activated killer cells in mice. , 1989, Journal of immunology.

[2]  R. Goldfarb,et al.  Interaction of tumor cells and immune system in the metastatic process. , 1988, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[3]  R. Penny,et al.  Natural killer cell activity in cardiac transplant recipients. , 1987, Transplantation.

[4]  S. Rosenberg,et al.  Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. , 1987, Journal of immunology.

[5]  V. Barnaba,et al.  Monitoring of NK-1 and NK-15 subsets and natural killer activity in kidney transplant recipients receiving cyclosporine. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

[6]  P. Guillou,et al.  THE RESPONSE TO INTERFERON OF NK AND K CELLS FROM CONVENTIONALLY IMMUNOSUPPRESSED AND CYCLOSPORINE‐TREATED RENAL ALLOGRAFT RECIPIENTS , 1984, Transplantation.

[7]  S. Schwartz,et al.  Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. , 1984, Journal of immunology.

[8]  Y. Koide,et al.  Natural cell-mediated cytotoxicity in long-term kidney transplant recipients. , 1981, Transplantation proceedings.

[9]  A. Mantovani,et al.  INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN A , 1981, Transplantation.

[10]  T. Starzl,et al.  Malignant tumors arising de novo in immunosuppressed organ transplant recipients. , 1972 .